Cécile V Denis Selected Research

Platelet Glycoprotein GPIb-IX Complex (Glycoprotein Ib)

1/2015	Apoptotic Platelet Events Are Not Observed in Severe von Willebrand Disease-Type 2B Mutation p.V1316M.
12/2013	von Willebrand factor mutation promotes thrombocytopathy by inhibiting integrin αIIbβ3.
1/2007	Role of von Willebrand factor in tumor metastasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cécile V Denis Research Topics

Disease

24	Thrombosis (Thrombus) 01/2022 - 03/2002
21	Hemorrhage 01/2022 - 03/2008
11	von Willebrand Diseases (von Willebrand's Disease) 01/2022 - 03/2007
7	Inflammation (Inflammations) 01/2022 - 01/2014
7	Hemophilia A (Haemophilia) 01/2020 - 02/2008
5	Thrombocytopenia (Thrombopenia) 07/2020 - 05/2014
4	Type 2 von Willebrand Disease 12/2019 - 12/2013
3	Neoplasms (Cancer) 01/2022 - 01/2007
3	Ischemic Stroke 01/2021 - 10/2010
3	Body Weight (Weight, Body) 11/2017 - 08/2009
2	Thrombotic Thrombocytopenic Purpura 10/2020 - 05/2014
2	Vascular System Injuries 01/2019 - 03/2016
2	Arterial Occlusive Diseases (Arterial Occlusive Disease) 08/2017 - 03/2002
1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 09/2022
1	Disseminated Intravascular Coagulation 01/2022
1	Hyperplasia 01/2022
1	Sepsis (Septicemia) 01/2022
1	Septic Shock (Toxic Shock Syndrome) 01/2022
1	Reperfusion Injury 01/2021
1	Brain Ischemia (Cerebral Ischemia) 01/2021
1	Thromboinflammation 01/2021
1	Hemophilia B (Haemophilia B) 12/2019
1	Obesity 03/2019
1	Weight Loss (Weight Reduction) 03/2019
1	Heart Failure 01/2019
1	Myocardial Infarction 01/2019
1	Leukemia 11/2018
1	Carotid Artery Thrombosis 08/2017
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 08/2017
1	Thrombotic Stroke 08/2017

Drug/Important Bio-Agent (IBA)

34	von Willebrand FactorIBA 01/2022 - 05/2002
9	CollagenIBA 11/2018 - 03/2008
8	Glycoproteins (Glycoprotein)IBA 01/2022 - 03/2004
8	Proteins (Proteins, Gene)FDA Link 10/2020 - 08/2010
6	IntegrinsIBA 01/2018 - 03/2002
5	Factor VIII (Coagulation Factor VIII)IBA 01/2020 - 02/2008
4	AntigensIBA 01/2022 - 03/2007
4	Hemostatics (Antihemorrhagics)IBA 01/2022 - 04/2012
4	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2021 - 04/2007
4	Thrombin FDA Link 12/2019 - 08/2017
4	LigandsIBA 11/2018 - 04/2007
3	Factor X (Stuart Factor)IBA 01/2020 - 02/2016
3	ferric chlorideIBA 08/2017 - 09/2012
3	Platelet Glycoprotein GPIb-IX Complex (Glycoprotein Ib)IBA 01/2015 - 01/2007
2	AnticoagulantsIBA 01/2022 - 11/2019
2	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 01/2021 - 03/2013
2	Messenger RNA (mRNA)IBA 01/2020 - 01/2017
2	AntibodiesIBA 01/2020 - 12/2019
2	Factor VIIa (Activated Factor VII)IBA 01/2020 - 07/2018
2	SerpinsIBA 01/2020 - 11/2019
2	Thromboplastin (Tissue Factor)IBA 11/2019 - 07/2018
2	Adenosine Diphosphate (ADP)IBA 03/2019 - 10/2015
2	Platelet Membrane GlycoproteinsIBA 01/2018 - 10/2016
2	Fibrillar CollagensIBA 10/2010 - 08/2008
2	Complementary DNA (cDNA)IBA 08/2008 - 03/2008
1	Congenital disorder of glycosylation type 1AIBA 09/2022
1	phosphomannomutaseIBA 09/2022
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2022
1	Dacarbazine (DIC)FDA LinkGeneric 01/2022
1	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2022
1	plasma protein Z (protein Z)IBA 01/2022
1	CytokinesIBA 04/2021
1	SuspensionsIBA 01/2021
1	Blood Proteins (Serum Proteins)IBA 10/2020
1	Explosive Agents (Explosives)IBA 10/2020
1	caplacizumabIBA 10/2020
1	Fibrinogen (Factor I)FDA Link 10/2020
1	Galactose (Galactopyranose)FDA LinkGeneric 07/2020
1	Anti-Idiotypic AntibodiesIBA 01/2020
1	Mannose (D-Mannose)IBA 01/2020
1	Protein CIBA 01/2020
1	Polysaccharides (Glycans)IBA 01/2020
1	Factor IXa (Coagulation Factor IXa)IBA 01/2020
1	emicizumabIBA 01/2020
1	lipoprotein-associated coagulation inhibitor (TFPI)IBA 01/2020
1	prothrombin complex concentrates (PPSB)IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	AntithrombinsIBA 01/2020
1	cancer procoagulantIBA 12/2019
1	Blood Coagulation Factors (Coagulation Factor)IBA 11/2019
1	Peptide Hydrolases (Proteases)FDA Link 11/2019
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 11/2019
1	CalciumIBA 03/2019
1	Biological ProductsIBA 01/2019
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2018
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 11/2018
1	convulxinIBA 11/2018
1	EphrinsIBA 11/2018
1	recombinant FVIIa (rFVIIa)FDA Link 07/2018
1	7,7'- dimethoxy- (4,4'- bi- 1,3- benzodioxole)- 5,5'- dicarboxylic acid dimethyl ester (BDD)IBA 01/2018
1	Monomeric GTP-Binding ProteinsIBA 01/2018
1	Protein Kinase CIBA 01/2018
1	Protein Isoforms (Isoforms)IBA 01/2018
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2018
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2018

Therapy/Procedure

5	Surgical Instruments (Clip) 01/2022 - 01/2017
3	Therapeutics 01/2020 - 01/2013
2	Lasers (Laser) 12/2019 - 08/2017
1	Ligation 01/2022
1	Hepatectomy 11/2017